Current Report Filing (8-k)
February 16 2018 - 1:43PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
February
14, 2018
Commission
File #:
000-53723
TAURIGA
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Florida
(State
or other jurisdiction of incorporation)
30-0791746
(IRS
Employer Identification Number)
555
Madison Avenue, 5
th
Floor
New
York, NY
(Address
of principal executive office)
Tel:
(917) 796-9926
(Registrant’s
telephone number)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Item
2.01 Completion of Acquisition or Disposition of Assets
Tauriga
Sciences, Inc. (the “Company”) participated in an $18,500,250 underwritten public offering by Blink Charging Co. (NASDAQ:
BLNK) (“Blink”), which closed on February 14, 2018. The Company invested $191,250 USD of its balance sheet cash and
purchased 45,000 registered shares of Blink common stock, as well as warrants exercisable immediately for a period of five (5)
years from the date of issuance for up to 90,000 additional shares of common stock of Blink. The Warrants carry an exercise price
of $4.25 per share, and also trade on the NASDAQ under the ticker symbol: BLNKW. The Company is in possession of the registered
securities as of the closing date.
The
Company currently holds:
A.
45,000 registered shares of BLNK
B.
90,000 registered shares of BLNKW
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
February 16, 2018
Seth
M. Shaw
|
|
X___SETH
M. SHAW____
|
|
Chief
Executive Officer
|
|
Tauriga
Sciences Inc.
|
|
Please see Exhibit Attached (“Exhibit A”) -- (Press Release from February 14, 2018)